(8R,9S,13S,14R,15R)-N-ethyl-13-methyl-3-(2-((S)-2-methylpyrrolidin-1-yl)ethoxy)-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-15-carboxamide

ID: ALA4467925

Chembl Id: CHEMBL4467925

PubChem CID: 155532528

Max Phase: Preclinical

Molecular Formula: C28H40N2O3

Molecular Weight: 452.64

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCNC(=O)[C@@H]1CC(=O)[C@@]2(C)CC[C@@H]3c4ccc(OCCN5CCC[C@@H]5C)cc4CC[C@H]3[C@H]12

Standard InChI:  InChI=1S/C28H40N2O3/c1-4-29-27(32)24-17-25(31)28(3)12-11-22-21-10-8-20(16-19(21)7-9-23(22)26(24)28)33-15-14-30-13-5-6-18(30)2/h8,10,16,18,22-24,26H,4-7,9,11-15,17H2,1-3H3,(H,29,32)/t18-,22+,23+,24+,26+,28+/m0/s1

Standard InChI Key:  UZLPYNNAGQTNCS-ZHFJTULBSA-N

Alternative Forms

  1. Parent:

    ALA4467925

    ---

Associated Targets(Human)

HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrm1 Muscarinic acetylcholine receptor (3770 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 452.64Molecular Weight (Monoisotopic): 452.3039AlogP: 4.34#Rotatable Bonds: 6
Polar Surface Area: 58.64Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.32CX LogP: 4.29CX LogD: 2.38
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.70Np Likeness Score: 0.14

References

1. Ledneczki I, Némethy Z, Tapolcsányi P, Éles J, Greiner I, Gábor E, Varga B, Balázs O, Román V, Lévay G, Mahó S..  (2019)  Discovery of novel steroidal histamine H3 receptor antagonists/inverse agonists. Part 2. Versatile steroidal carboxamide derivatives.,  29  (20): [PMID:31492518] [10.1016/j.bmcl.2019.126643]

Source